Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/18/2025

Fever Management Guidelines

Introduction to Fever Benefits

  • The Society of Critical Care Medicine recommends that fever should not be routinely treated with antipyretics solely to reduce temperature, as it represents a protective physiological response against infections, and its reduction does not improve mortality or clinical outcomes 1, 2
  • Inhibiting bacterial replication of pathogens like N. meningitidis and S. pneumoniae is achieved through fever, with better outcomes in patients with CNS infections when temperature reaches 38-39.4°C 2

Evidence Against Routine Fever Treatment

  • A meta-analysis of 13 randomized controlled trials demonstrated that antipyretic therapy does not improve 28-day mortality in critically ill patients 2, 3
  • The use of paracetamol in septic patients reduces temperature by only 0.3°C but does not influence mortality or duration of intensive care unit stay 2
  • The Society of Critical Care Medicine explicitly recommends not to use antipyretics routinely for the purpose of reducing temperature, as this has not been shown to improve mortality 1, 2, 3

Pediatric Considerations

  • In pediatric studies, the response to antipyretics does not correlate with the probability of severe bacterial infection 4, 5

Specific Clinical Contexts

  • In bacterial meningitis without increased intracranial pressure, normothermia is suggested to improve survival and neurological outcome 2
  • In septic shock, normothermia is suggested, not aggressive suppression of fever below 36°C 2
  • For neutropenic patients, fever requires immediate empirical antibiotics regardless of temperature control 1, 3
  • Temperature management does not replace antimicrobial therapy 2

Practical Management Algorithm

  • For stable immunocompetent patients, do not routinely administer antipyretics solely to reduce temperature 2
  • Offer antipyretics if the patient requests symptomatic relief 1, 2
  • Focus on identifying and treating the underlying cause 1, 2

Important Caveats

  • Delaying identification and treatment of the underlying infection while focusing on temperature control is a critical error 2, 3
  • Assuming that fever suppression improves infectious outcomes when it actually does not influence mortality is a fundamental error 2
  • Using unreliable methods of temperature measurement (tympanic, temporal) for clinical decisions is discouraged 1, 2
  • For patients with COVID-19 symptoms, paracetamol is preferred over NSAIDs until more evidence is available, but antipyretics should not be used solely to reduce body temperature 3

REFERENCES

1

Guidelines for Treating Fever [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Fever Management in Critically Ill Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Management of Persistent Fever Despite Antipyretics [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025